Furthermore, this protective anti-degenerative effect of PPARγ activation has been demonstrated to persist in front of pro-degenerative co-morbidities like metabolic syndrome (Assmann A. K. et al., 2022) and diabetes (Katahira et al., 2021). Here, PPARG is linked to diabetes mellitus.